Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Anatomic Stage IV Breast Cancer AJCC v8 1

Interventions

Specimen Handling 40Magnetic Resonance Spectroscopy 28Carboplatin 19Gemcitabine 18Biopsy 17Cyclophosphamide 15fludarabine 14Paclitaxel 14Cisplatin 14pembrolizumab 13Oxaliplatin 12Dexamethasone 12Radiotherapy 11Injections 11Nivolumab 10Interviews as Topic 9venetoclax 8Irinotecan 8Fluorouracil 8Bevacizumab 8X-Rays 7Radiosurgery 7Drug Therapy 7Capecitabine 7Bortezomib 7cemiplimab 6Rituximab 6Pemetrexed 6Doxorubicin 6Calcium Dobesilate 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Cyclin-Dependent Kinase Inhibitor p18 × 30 days × Clear all
NCT07578116 2026-05-27

Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis

SWOG Cancer Research Network

Phase 3 Not yet recruiting
562 enrolled
Breast

Anatomic Stage IV Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡